Navigation Links
Ben-Gurion U. researchers receive US-AID MERC grant for water project with the Palestinian authority
Date:8/13/2010

BEER-SHEVA, ISRAEL, August 13, 2010 -- Ben-Gurion University of the Negev's (BGU) Dr. Moshe Herzberg and Prof. Mohammed Saleem Ali-Shtayeh of the Biodiversity and Environmental Research Center (BERC) in Nablus received a significant grant to increase the clean water supply around Israel and the Middle East. This study brings together Israelis and Palestinians to address clean water issues in the West Bank area of Nablus over a five-year period.

The US-AID MERC grant for $659,410 will address biofouling of Reverse Osmosis (RO) membranes during reclamation of secondary wastewater. Reverse Osmosis membrane filtration is normally used for desalination and reclamation of secondary effluents, removing organics and undesired salts from water. The grant project, "Reclamation of Secondary Effluents with Reverse Osmosis Membranes (RO): Fouling Mechanisms and Control," will focus on the mechanisms by which microbial biofilm formation on RO membranes ("biofouling") impacts the decrease in membrane performance. It will also suggest novel ways to mitigate biofouling and clean biofouled membranes.

According to Dr. Herzberg, "These techniques can be applied to increase access to clean water supply in the Middle East, especially in the Palestinian Authority and Israel. Purified secondary wastewater is an immediate resource for irrigation and after RO filtration those waters can be used indirectly for drinking."

The researchers, Dr. Moshe Herzberg (BGU), Dr. Osnat Gillor (BGU), Prof. Mohammed Saleem Ali-Shtayeh (BERC) and Dr. Helen Thanh Nguyen, a grant advisor and assistant professor at the University of Illinois Urbana-Champaign, are planning to characterize and eventually find novel ways to eradicate different biofilms grown on RO membranes. Biofilm characterization will include adhesion properties, microbial community structure, growth kinetics and chemical structure.


'/>"/>

Contact: Andrew Lavin
andrewlavin@alavin.com
516-353-3505
American Associates, Ben-Gurion University of the Negev
Source:Eurekalert

Page: 1

Related biology news :

1. Ben-Gurion University of the Negev professor awarded the 2010 Elkeles Prize for Cancer Research
2. Ben-Gurion University of the Negev researchers identify risks of hypertension in young adults
3. FDA approves trial for type 1 diabetes treatment by Ben-Gurion U. and U. Colorado
4. Ben-Gurion U researchers isolate microalgal strain that could reduce cholesterol
5. Uniform method to interpret autism spectrum disorders is defined at Ben-Gurion University
6. Anti-inflammatory drugs (coxibs) interfere with aspirins clotting ability -- Ben-Gurion U.
7. Heartburn drugs deemed safe for fetuses according to Ben-Gurion University researchers
8. Ben-Gurion University Alzheimers researcher demonstrates specific immune response to vaccine
9. Ben-Gurion University of the Negev technology being developed for use in Jordan desalination plant
10. Ben-Gurion U. developing new computer techniques to analyze historic Hebrew and Arabic documents
11. 1 in 6 health workers wont report in flu pandemic -- study by Ben-Gurion U. researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... 7, 2016   Avanade is helping Williams ... teams in history, exploit biometric data in order to ... maintain the competitive edge against their rivals after their ... Avanade has worked with Williams during the 2016 ... data (heart rate, breathing rate, temperature and peak acceleration) ...
(Date:12/6/2016)... Valencell , the leading innovator in performance biometric ... consecutive year of triple digit growth for its PerformTek ... 360 percent increase in companies who have acquired Valencell ... sales of its wrist and ear Benchmark™ sensor systems, ... hearables for fitness and healthcare applications. ...
(Date:12/2/2016)... India , December 1, 2016 ... Authentication type (Fingerprint, Voice), Future Technology (Iris Recognition ... and Region - Global Forecast to 2021", published ... USD 442.7 Million in 2016, and is projected ... at a CAGR of 14.06%.      ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Renova™ Therapeutics, ... congestive heart failure and type 2 diabetes, announced ... a novel adeno-associated virus (AAV) vector developed in ... M.D., Ph.D., at Stanford University. The company plans ... paracrine gene therapy product pipeline. ...
(Date:12/8/2016)... 8, 2016 Oxford ... erweitert seine Palette an anpassbaren SureSeq™ NGS-Panels mit ... Panels, das ein schnelles und kostengünstiges Studium der ... bietet eine Erkennung von Einzel-Nukleotid-Variationen (Single Nucleotide Variation, ... einzigen kleinen Panel und ermöglicht eine individuelle Anpassung ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... packaging for their exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. ... bioprocess media products engineered to radically streamline culture processes, minimize processing time, ...
(Date:12/8/2016)... Dec. 8, 2016 Soligenix, Inc. (OTCQB: SNGX) ... on developing and commercializing products to treat rare diseases ... that it will be hosting an Investor Webcast Event ... the origins of innate defense regulators (IDRs) as a ... oral mucositis and the recently announced and published Phase ...
Breaking Biology Technology: